Literature DB >> 30538336

The transcription factor c-Maf is essential for the commitment of IL-17-producing γδ T cells.

Matthew K Zuberbuehler1, Morgan E Parker1, Joshua D Wheaton1, Jaclyn R Espinosa1, Harmony R Salzler1, Eunchong Park1, Maria Ciofani2.   

Abstract

γδ T cells that produce the cytokine IL-17 (Tγδ17 cells) are innate-like mediators of immunity that undergo effector programming in the thymus. While regulators of Tγδ17 specialization restricted to various Vγ subsets are known, a commitment factor essential to all Tγδ17 cells has remained undefined. In this study, we identified the transcription factor c-Maf as a universal regulator of Tγδ17 cell differentiation and maintenance. Maf deficiency caused an absolute lineage block at the immature CD24+CD45RBlo γδ thymocyte stage, which revealed a critical checkpoint in the acquisition of effector functions. Here, c-Maf enforced Tγδ17 cell identity by promoting chromatin accessibility and expression of key type 17 program genes, notably Rorc and Blk, while antagonizing the transcription factor TCF1, which promotes interferon-γ-producing γδ T cells (Tγδ1 cells). Furthermore, γδ T cell antigen receptor (γδTCR) signal strength tuned c-Maf expression, which indicates that c-Maf is a core node that connects γδTCR signals to Tγδ17 cell transcriptional programming.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30538336      PMCID: PMC6294311          DOI: 10.1038/s41590-018-0274-0

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  64 in total

1.  Synergistic transcription activation by Maf and Sox and their subnuclear localization are disrupted by a mutation in Maf that causes cataract.

Authors:  Nirmala Rajaram; Tom K Kerppola
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

2.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Bioinformatics       Date:  2013-11-13       Impact factor: 6.937

3.  RelA and RelB transcription factors in distinct thymocyte populations control lymphotoxin-dependent interleukin-17 production in γδ T cells.

Authors:  Iwona Powolny-Budnicka; Marc Riemann; Simone Tänzer; Roland M Schmid; Thomas Hehlgans; Falk Weih
Journal:  Immunity       Date:  2011-03-25       Impact factor: 31.745

4.  The homogeneity of the TCRdelta repertoire expressed by the Thy-1dull gammadelta T cell population is due to cellular selection.

Authors:  V Azuara; M P Lembezat; P Pereira
Journal:  Eur J Immunol       Date:  1998-11       Impact factor: 5.532

Review 5.  Thymic Determinants of γδ T Cell Differentiation.

Authors:  Miguel Muñoz-Ruiz; Nital Sumaria; Daniel J Pennington; Bruno Silva-Santos
Journal:  Trends Immunol       Date:  2017-03-09       Impact factor: 16.687

6.  A validated regulatory network for Th17 cell specification.

Authors:  Maria Ciofani; Aviv Madar; Carolina Galan; Maclean Sellars; Kieran Mace; Florencia Pauli; Ashish Agarwal; Wendy Huang; Christopher N Parkhurst; Michael Muratet; Kim M Newberry; Sarah Meadows; Alex Greenfield; Yi Yang; Preti Jain; Francis K Kirigin; Carmen Birchmeier; Erwin F Wagner; Kenneth M Murphy; Richard M Myers; Richard Bonneau; Dan R Littman
Journal:  Cell       Date:  2012-09-25       Impact factor: 41.582

7.  HEB is required for the specification of fetal IL-17-producing γδ T cells.

Authors:  Tracy S H In; Ashton Trotman-Grant; Shawn Fahl; Edward L Y Chen; Payam Zarin; Amanda J Moore; David L Wiest; Juan Carlos Zúñiga-Pflücker; Michele K Anderson
Journal:  Nat Commun       Date:  2017-12-08       Impact factor: 14.919

8.  Strong TCRγδ Signaling Prohibits Thymic Development of IL-17A-Secreting γδ T Cells.

Authors:  Nital Sumaria; Capucine L Grandjean; Bruno Silva-Santos; Daniel J Pennington
Journal:  Cell Rep       Date:  2017-06-20       Impact factor: 9.423

9.  CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity.

Authors:  H S Azzam; A Grinberg; K Lui; H Shen; E W Shores; P E Love
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

10.  Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections.

Authors:  Heather R Conti; Alanna C Peterson; Lucas Brane; Anna R Huppler; Nydiaris Hernández-Santos; Natasha Whibley; Abhishek V Garg; Michelle R Simpson-Abelson; Gregory A Gibson; Anna J Mamo; Lisa C Osborne; Shrinivas Bishu; Nico Ghilardi; Ulrich Siebenlist; Simon C Watkins; David Artis; Mandy J McGeachy; Sarah L Gaffen
Journal:  J Exp Med       Date:  2014-09-08       Impact factor: 14.307

View more
  42 in total

Review 1.  Thymic development of unconventional T cells: how NKT cells, MAIT cells and γδ T cells emerge.

Authors:  Daniel G Pellicci; Hui-Fern Koay; Stuart P Berzins
Journal:  Nat Rev Immunol       Date:  2020-06-24       Impact factor: 53.106

2.  Critical Role for SLAM/SAP Signaling in the Thymic Developmental Programming of IL-17- and IFN-γ-Producing γδ T Cells.

Authors:  Oliver Dienz; Victoria L DeVault; Shawn C Musial; Somen K Mistri; Linda Mei; Aleksandr Baraev; Julie A Dragon; Dimitry Krementsov; Andre Veillette; Jonathan E Boyson
Journal:  J Immunol       Date:  2020-02-05       Impact factor: 5.422

3.  IL-17-producing γδ T cells protect against Clostridium difficile infection.

Authors:  Yee-Shiuan Chen; Iuan-Bor Chen; Giang Pham; Tzu-Yu Shao; Hansraj Bangar; Sing Sing Way; David B Haslam
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

4.  Clonal Vγ6+Vδ4+ T cells promote IL-17-mediated immunity against Staphylococcus aureus skin infection.

Authors:  Mark C Marchitto; Carly A Dillen; Haiyun Liu; Robert J Miller; Nathan K Archer; Roger V Ortines; Martin P Alphonse; Alina I Marusina; Alexander A Merleev; Yu Wang; Bret L Pinsker; Angel S Byrd; Isabelle D Brown; Advaitaa Ravipati; Emily Zhang; Shuting S Cai; Nathachit Limjunyawong; Xinzhong Dong; Michael R Yeaman; Scott I Simon; Wei Shen; Scott K Durum; Rebecca L O'Brien; Emanual Maverakis; Lloyd S Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-14       Impact factor: 11.205

5.  The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5.

Authors:  Darshana Kadekar; Rasmus Agerholm; John Rizk; Heidi A Neubauer; Tobias Suske; Barbara Maurer; Monica Torrellas Viñals; Elena M Comelli; Amel Taibi; Richard Moriggl; Vasileios Bekiaris
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

6.  STAT3 but not STAT4 is critical for γδT17 cell responses and skin inflammation.

Authors:  Rasmus Agerholm; John Rizk; Mònica Torrellas Viñals; Vasileios Bekiaris
Journal:  EMBO Rep       Date:  2019-09-24       Impact factor: 8.807

7.  Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer.

Authors:  Min Liu; Zan Tong; Chuanlin Ding; Fengling Luo; Shouzhen Wu; Caijun Wu; Sabrin Albeituni; Liqing He; Xiaoling Hu; David Tieri; Eric C Rouchka; Michito Hamada; Satoru Takahashi; Andrew A Gibb; Goetz Kloecker; Huang-Ge Zhang; Michael Bousamra; Bradford G Hill; Xiang Zhang; Jun Yan
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

8.  Increased interleukin-17A-producing γδT cells predict favorable survival in elderly patients with LUAD and LUSC.

Authors:  Kele Cui; Xinyu Mei; Min Cheng
Journal:  J Cancer Res Clin Oncol       Date:  2021-07-29       Impact factor: 4.553

9.  MicroRNA-221 and -222 modulate intestinal inflammatory Th17 cell response as negative feedback regulators downstream of interleukin-23.

Authors:  Yohei Mikami; Rachael L Philips; Giuseppe Sciumè; Franziska Petermann; Françoise Meylan; Hiroyuki Nagashima; Chen Yao; Fred P Davis; Stephen R Brooks; Hong-Wei Sun; Hayato Takahashi; Amanda C Poholek; Han-Yu Shih; Behdad Afzali; Stefan A Muljo; Markus Hafner; Yuka Kanno; John J O'Shea
Journal:  Immunity       Date:  2021-03-02       Impact factor: 31.745

Review 10.  Interleukin-17 and ischaemic stroke.

Authors:  Qiaohui Zhang; Yan Liao; Zhenquan Liu; Yajie Dai; Yunxin Li; Yue Li; Yibo Tang
Journal:  Immunology       Date:  2020-10-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.